CRISTIANO, GIANLUCA
 Distribuzione geografica
Continente #
AS - Asia 1.750
NA - Nord America 1.300
EU - Europa 960
AF - Africa 126
SA - Sud America 111
Continente sconosciuto - Info sul continente non disponibili 84
OC - Oceania 5
Totale 4.336
Nazione #
US - Stati Uniti d'America 1.244
IT - Italia 479
CN - Cina 456
SG - Singapore 445
VN - Vietnam 374
KR - Corea 114
HK - Hong Kong 113
NL - Olanda 83
DE - Germania 80
BR - Brasile 79
SE - Svezia 63
IN - India 58
BD - Bangladesh 57
FI - Finlandia 52
FR - Francia 42
CI - Costa d'Avorio 33
SC - Seychelles 32
CA - Canada 30
GB - Regno Unito 29
JP - Giappone 28
IE - Irlanda 25
AT - Austria 18
RU - Federazione Russa 18
TG - Togo 17
ID - Indonesia 16
ZA - Sudafrica 16
PH - Filippine 15
MX - Messico 13
TH - Thailandia 12
BG - Bulgaria 11
JO - Giordania 11
EC - Ecuador 10
ES - Italia 10
PL - Polonia 10
TR - Turchia 10
NG - Nigeria 9
AR - Argentina 8
CH - Svizzera 7
EG - Egitto 7
IQ - Iraq 7
LT - Lituania 7
PK - Pakistan 6
TW - Taiwan 6
PT - Portogallo 5
AU - Australia 4
BE - Belgio 4
CR - Costa Rica 4
IR - Iran 4
JM - Giamaica 4
SA - Arabia Saudita 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
MA - Marocco 3
MK - Macedonia 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
CO - Colombia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GD - Grenada 2
HR - Croazia 2
KZ - Kazakistan 2
RS - Serbia 2
SI - Slovenia 2
AL - Albania 1
BO - Bolivia 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
LI - Liechtenstein 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
UA - Ucraina 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.253
Città #
Singapore 326
Hefei 181
Ashburn 174
San Jose 148
Bologna 113
Ho Chi Minh City 111
Seoul 104
Hong Kong 102
Hanoi 94
Chandler 66
Milan 60
New York 59
Dallas 57
Council Bluffs 50
Helsinki 39
Boardman 36
Ann Arbor 35
Abidjan 33
Beijing 32
Santa Clara 32
Dublin 25
Los Angeles 23
Tokyo 22
Rome 21
Lauterbourg 19
Fairfield 17
Frankfurt am Main 17
Lomé 17
Bengaluru 16
Haiphong 16
Johannesburg 16
Amsterdam 15
Buffalo 14
Da Nang 14
Florence 14
Munich 14
Princeton 14
São Paulo 14
Amman 11
Redmond 11
Sofia 11
Turin 11
Vienna 11
Southend 10
Abeokuta 9
Atlanta 9
Guangzhou 9
Jakarta 9
Stockholm 9
Falkenstein 8
Manaus 8
Nuremberg 8
Orem 8
Redondo Beach 8
Tianjin 8
Bangkok 7
Bremen 7
Chicago 7
Lappeenranta 7
London 7
Shanghai 7
Modena 6
Naples 6
Parma 6
Phoenix 6
Ravenna 6
Reggio Emilia 6
Seattle 6
Tongling 6
Toronto 6
Warsaw 6
Wilmington 6
Wuhan 6
Biên Hòa 5
Castel Maggiore 5
Cesena 5
Cosenza 5
Irvine 5
Mexico City 5
Montreal 5
Nanjing 5
Paris 5
San Francisco 5
Treviglio 5
Turku 5
York 5
Ankara 4
Berlin 4
Boston 4
Brussels 4
Catania 4
Chengdu 4
Chennai 4
Des Moines 4
Fortaleza 4
Hyderabad 4
Hải Dương 4
New Delhi 4
Osimo 4
Piscataway 4
Totale 2.553
Nome #
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 295
Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients 247
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 242
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 234
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study 231
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 212
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents 208
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms 205
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 204
Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia 202
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia 189
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study 175
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells 170
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets 167
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 159
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 158
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment 132
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 131
Release of IFNg by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells 130
COMPARISON BETWEEN NGS IGH/TCR AND RT-PCR BCR::ABL1 MINIMAL RESIDUAL DISEASE IN PH+ ACUTE LYMPHOBLASTIC LEUKEMIA: A PRELIMINARY ANALYSIS 128
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement 120
Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia 112
Single-Cell Metabolic Profiling Integrated with Extracellular Vesicle Analysis Reveals Novel Metabolic Vulnerabilities and Prognostic Biomarkers in Acute Myeloid Leukemia 99
Extracellular Vesicle-Based Liquid Biopsy Shows Clinical Relevance and Reveals Links with Single-Cell Metabolic Signature in Acute Myeloid Leukemia 71
Acute myeloid leukemia mutations: Therapeutic implications 56
IDH1/2 Mutations Are Maintained in a Subset of Patients with Acute Myeloid Leukemia in Complete Remission and Do Not Correlate with Residual Disease 46
Dynamics of IDH1/2 mutated clones in acute myeloid leukemia challenge their use as universal MRD markers 13
Totale 4.336
Categoria #
all - tutte 11.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022212 0 0 6 10 15 8 9 32 16 30 57 29
2022/2023386 37 43 10 35 54 31 10 38 68 8 32 20
2023/2024208 16 19 9 28 15 34 7 18 11 16 29 6
2024/2025863 26 102 46 48 41 38 83 56 56 81 103 183
2025/20262.458 215 335 199 220 155 109 206 87 481 169 150 132
2026/2027197 82 115 0 0 0 0 0 0 0 0 0 0
Totale 4.336